Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             154 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2017
 122 S1 p. 74-78
5 p.
 artikel
2 Copyright 2017
 122 S1 p. ii-
1 p.
 artikel
3 Information for Authors 2017
 122 S1 p. iii-
1 p.
 artikel
4 OC-044: ART DECO (CRUK/10/018): dose escalated vs standard dose IMRT in locally advanced head and neck cancer Nutting, C.
 2017
 122 S1 p. 24-
1 p.
 artikel
5 OC-022: Association of patient derived xenograft formation with oral cavity squamous cell cancer outcomes Hope, A.
 2017
 122 S1 p. 15-
1 p.
 artikel
6 OC-021: Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN Soulières, D.
 2017
 122 S1 p. 14-
1 p.
 artikel
7 OC-008: Incidence of malignant disease outside the head and neck region in head and neck cancer Bernsdorf, M.
 2017
 122 S1 p. 7-8
2 p.
 artikel
8 OC-006: Outcomes of head and neck cancer with N3 nodal disease: a review of the National Cancer Data Base Ko, H.C.
 2017
 122 S1 p. 6-7
2 p.
 artikel
9 OC-045: Recurrence patterns after 40Gy to the elective treated neck in head and neck cancer. Nevens, D.
 2017
 122 S1 p. 24-25
2 p.
 artikel
10 OC-043: Re-irradiation in head and neck cancers: A single institution prospective cohort study Salunkhe, R.
 2017
 122 S1 p. 23-24
2 p.
 artikel
11 OC-042: Re-irradiation with curative intent of squamous cell carcinomas of the head and neck in Denmark Engelmann, B.E.
 2017
 122 S1 p. 23-
1 p.
 artikel
12 OC-020: Sarcopenia predicts chemotherapy dose-limiting toxicity in patients with head and neck cancer Bril, S.I.
 2017
 122 S1 p. 13-
1 p.
 artikel
13 OC-007: Sentinel node biopsy for early stage oral cancer; experience of 2 Dutch head and neck centers Den Toom, I.
 2017
 122 S1 p. 7-
1 p.
 artikel
14 OC-019: The phase III study INTERCEPTOR: preliminary results Denaro, N.
 2017
 122 S1 p. 12-13
2 p.
 artikel
15 OC-009: Validation of a prognostic model in 600 patients with squamous cell carcinoma Rasmussen, J.H.
 2017
 122 S1 p. 8-9
2 p.
 artikel
16 PD-029: Causes-of-death underestimate the burden of head and neck cancers in France (EPICORL study) Pointreau, Y.
 2017
 122 S1 p. 17-18
2 p.
 artikel
17 PD-033: Cetuximab + RT shows an excellent long term OS in patients with both high ADCC and high EGFR Merlano, M.
 2017
 122 S1 p. 19-20
2 p.
 artikel
18 PD-027: cfHPV DNA as a marker of treatment results in patients with HPV-related head and neck cancer. Rutkowski, T.
 2017
 122 S1 p. 16-17
2 p.
 artikel
19 PD-026: Correlation and prognostic impact of HPV and p16 on RT-outcome in larynx and hypopharynx cancer Lassen, P.
 2017
 122 S1 p. 16-
1 p.
 artikel
20 PD-032: Pharyngeal constrictor muscle dose correlated with dysphagia after radiotherapy in head and neck Miroir, J.
 2017
 122 S1 p. 19-
1 p.
 artikel
21 PD-028: Prognostic and predictive impact of HPV status in oropharyngeal cancer: the MARCH-HPV project Lacas, B.
 2017
 122 S1 p. 17-
1 p.
 artikel
22 PD-031: Quality of life, health status and work in head and neck cancer survivors treated with radiotherapy Matías-Pérez, A.
 2017
 122 S1 p. 18-19
2 p.
 artikel
23 PD-034: Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer Orlandi, E.
 2017
 122 S1 p. 20-
1 p.
 artikel
24 PD-030: Survival of patients with head and neck cancers in France (EPICORL study) Huguet, F.
 2017
 122 S1 p. 18-
1 p.
 artikel
25 PO-118: Acute and late toxicities in patients with oral cancer treated with intensity-modulated radiotherapy Cristaudo, A.
 2017
 122 S1 p. 56-57
2 p.
 artikel
26 PO-083: Adaptative radiotherapy for nasopharyngeal carcinoma Farhat, L.
 2017
 122 S1 p. 39-40
2 p.
 artikel
27 PO-087: Adaptive 18F-FDG-PET-guided reirradiation for recurrent and second primary head and neck cancer Schatteman, J.
 2017
 122 S1 p. 41-42
2 p.
 artikel
28 PO-141: Adenoid cystic carcinoma of the head and neck: solid growth pattern as an adverse prognostic factor Fonseca, J.
 2017
 122 S1 p. 67-68
2 p.
 artikel
29 PO-115: A [18F] FDG-PET adaptive thresholding algorithm delineation of RT tumour volumes of head and neck cancer Deantonio, L.
 2017
 122 S1 p. 55-
1 p.
 artikel
30 PO-150: Age ≥70 is not an adverse prognostic factor for accelerated radiotherapy in head and neck cancer Terhaard, C.
 2017
 122 S1 p. 72-73
2 p.
 artikel
31 PO-114: Alterations in tumour hypoxia in serial FMISO/PET-CT during chemoradiation in HNSCC Bunea, H.
 2017
 122 S1 p. 55-
1 p.
 artikel
32 PO-124: A melatonin gel protects the mitochondria from radiation damage preventing mucositis Escames, G.
 2017
 122 S1 p. 59-
1 p.
 artikel
33 PO-110: Analysis of loco-regional failures after IMRT for HNSCC using deformable image registration Zukauskaite, R.
 2017
 122 S1 p. 53-
1 p.
 artikel
34 PO-051: A 7-year overview on advanced nasopharynx’s cancer: features influencing survival outcomes Nogueira, A.
 2017
 122 S1 p. 26-27
2 p.
 artikel
35 PO-142: A 10-year review of primary major salivary glands carcinomas Magalhães, H.
 2017
 122 S1 p. 68-
1 p.
 artikel
36 PO-086: Brachial plexus position reproducibility for head and neck radiotherapy and it’s dosimetric impact English, S.
 2017
 122 S1 p. 41-
1 p.
 artikel
37 PO-080: Challenges and opportunities in head and neck cancer research in the UK: a survey of oncologists Foran, B.
 2017
 122 S1 p. 38-39
2 p.
 artikel
38 PO-144: Chronic radiation-associated dysphagia after curative reirradiation. Does age affect? Gutierrez Bayard, L.
 2017
 122 S1 p. 69-
1 p.
 artikel
39 PO-077: Cisplatin or Carboplatin in locally advanced head and neck squamous cell carcinoma Bahie eldin, N.
 2017
 122 S1 p. 37-
1 p.
 artikel
40 PO-054: Cisplatin use in UK head and neck cancer management: a clinician survey of current practice Foran, B.
 2017
 122 S1 p. 27-28
2 p.
 artikel
41 PO-107: Clinical outcomes of HPV-positive non-oropharyngeal squamous cell carcinoma: analysis of the NCDB Ko, H.
 2017
 122 S1 p. 51-52
2 p.
 artikel
42 PO-072: Compliance and acute toxicity of chemoradiotherapy for undifferentiated nasopharyngeal cancer Jovanovic Korda, N.
 2017
 122 S1 p. 35-36
2 p.
 artikel
43 PO-074: Concomitant chemoradiotherapy alone or with induction chemotherapy in advanced head and neck cancer. Teixeira, R.
 2017
 122 S1 p. 36-
1 p.
 artikel
44 PO-126: Consenting patients for late-effects of head and neck radiotherapy: an audit of UK oncology practice Christian, J.A.
 2017
 122 S1 p. 60-
1 p.
 artikel
45 PO-070: Conventional vs bifractionated radiotherapy innasopharyngeal cancer 10years followup of phase3 trial Siala, W.
 2017
 122 S1 p. 34-35
2 p.
 artikel
46 PO-082: Correlation between HI, GI, CI and Size of Metastases for Linac-Based High Dose SRT / SRS Tas, B.
 2017
 122 S1 p. 39-
1 p.
 artikel
47 PO-093: COSTAR trial results: 3-D Conformal Radiotherapy vs Cochlea-Sparing IMRT in parotid cancer patients Nutting, C.
 2017
 122 S1 p. 44-45
2 p.
 artikel
48 PO-145: Definitive sequential radiotherapy in elderly patients with locally advanced oropharyngeal cancer De Felice, F.
 2017
 122 S1 p. 69-70
2 p.
 artikel
49 PO-111: Dermal backflow: NIRFLI pattern associated multimodality therapy in patients with oropharynx cancer Naqvi, S.
 2017
 122 S1 p. 53-54
2 p.
 artikel
50 PO-119: Does mucosal appearance predict mucosal PRO in oropharyngeal carcinoma treated with chemoimrt? Hickman, M.
 2017
 122 S1 p. 57-
1 p.
 artikel
51 PO-060: Dose received by the pituitary gland during irradiation of nasopharyngeal carcinoma Sellami, N.
 2017
 122 S1 p. 30-
1 p.
 artikel
52 PO-071: Dose to the thyroid gland during irradiation of nasopharyngeal carcinoma Siala, W.
 2017
 122 S1 p. 35-
1 p.
 artikel
53 PO-092: Dosimetric comparaison of conformal and intensity modulated radiotherapy for locally recurrent NPC Mnejja, W.
 2017
 122 S1 p. 44-
1 p.
 artikel
54 PO-096: Dosimetric evalutation of volumetric modulated arc therapy (VMAT) in sinonasal cancer raiotherapy Donini, E.
 2017
 122 S1 p. 46-
1 p.
 artikel
55 PO-097: Droplet Digital PCR for detection of circulating tumour DNA in blood of head and neck cancer patients Van Ginkel, J.H.
 2017
 122 S1 p. 46-
1 p.
 artikel
56 PO-113: Dynamics of biological imaging parameters in PW-MRI and FMISO-PET/CT during chemoradiation of SCCHN Bunea, A.
 2017
 122 S1 p. 54-55
2 p.
 artikel
57 PO-066: Early-stage tonsil cancer submitted to primary surgery and adjuvant therapy: retrospective study Pedro, C.
 2017
 122 S1 p. 33-
1 p.
 artikel
58 PO-125: Effects of melatonin oral gel to prevent radiation-induced mucositis model in rat Escames, G.
 2017
 122 S1 p. 59-60
2 p.
 artikel
59 PO-059: Efficacy and safety of modified-increased FEP regimen and chemo-radiation for locally advanced HNSCC Ouhajjou, A.
 2017
 122 S1 p. 30-
1 p.
 artikel
60 PO-102: EGFR detection in saliva as an easy diagnostic and prognostic tool in oral squamous cell cancer Piazza, C.
 2017
 122 S1 p. 49-
1 p.
 artikel
61 PO-095: Electrochemotherapy for mucosal head and neck tumours: results from a phase II clinical trial. Plaschke, C.C.
 2017
 122 S1 p. 45-46
2 p.
 artikel
62 PO-104: Everolimus in oral cancer: a potential therapeutic approach dependent on cell type? Domingues, C.
 2017
 122 S1 p. 50-
1 p.
 artikel
63 PO-121: Fentanyl Pectin Nasal Spray in head and neck cancer irradiation. First results of the PecDICO study Pointreau, Y.
 2017
 122 S1 p. 58-
1 p.
 artikel
64 PO-128: Follow up dysphagia in head and neck cancers is related to RT dose received by swallowing structures George, K.
 2017
 122 S1 p. 61-62
2 p.
 artikel
65 PO-084: HDR Interstitial Brachytherapy for head and neck malignancies with Iridium 192 implants Pareek, V.
 2017
 122 S1 p. 40-
1 p.
 artikel
66 PO-068: Head and neck cancer of unknown primary origin: a single institution experience Ferreira, N.
 2017
 122 S1 p. 34-
1 p.
 artikel
67 PO-120: Head and neck cancers are associated with poor EQ-5D-related utility in France (EPICORL study) Schwarzinger, M.
 2017
 122 S1 p. 57-
1 p.
 artikel
68 PO-135: Head and neck squamous cell carcinoma of unknown primary treated in the era of FDG-PET and IMRT De Ridder, M.
 2017
 122 S1 p. 65-
1 p.
 artikel
69 PO-136: Hospital costs associated with head and neck cancer by phase-of-care in France (EPICORL study) Schwarzinger, M.
 2017
 122 S1 p. 65-
1 p.
 artikel
70 PO-099: Human papillomavirus in head and neck cancer in the UK: a clinician survey of current practice Foran, B.
 2017
 122 S1 p. 47-48
2 p.
 artikel
71 PO-139: Hypofractionated accelerated chemo-Tomotherapy for nasopharyngeal cancer: 2-year treatment outcomes Fong, C.T.K.
 2017
 122 S1 p. 66-67
2 p.
 artikel
72 PO-148: Hypofractionated radiotherapy for head and neck cancer patients unfit for standard treatment Desideri, I.
 2017
 122 S1 p. 71-
1 p.
 artikel
73 PO-079: Hypofractionated versus prolonged chemo-IMRT schedules in oropharyngeal carcinoma Boon, I.
 2017
 122 S1 p. 38-
1 p.
 artikel
74 PO-123: Hypothyroidism after radiotherapy of head and neck – incidence and risk factors. Dworzecka, U.
 2017
 122 S1 p. 59-
1 p.
 artikel
75 PO-151: Immunotherapy for refractory brain metastasis in cases of oropharangeal squamous cell carcinoma Bhandari, M.
 2017
 122 S1 p. 73-
1 p.
 artikel
76 PO-053: Impact of PTV coverage on local recurrences and overall survival after IMRT for head and neck cancers Piram (France), L.
 2017
 122 S1 p. 27-
1 p.
 artikel
77 PO-138: IMRT of sino-nasal cancer: improved results compared to 3D radiotherapy. Frédéric-Moreau, T.
 2017
 122 S1 p. 66-
1 p.
 artikel
78 PO-091: Intensity modulated radiotherapy (IMRT) in nasopharyngeal cancer – a dosimetric and QoL analysis Pareek, V.
 2017
 122 S1 p. 44-
1 p.
 artikel
79 PO-105: Is there justification for age bias in HPV p16 testing for Oropharyngeal Squamous Cell Carcinoma? McCauley, S.
 2017
 122 S1 p. 50-51
2 p.
 artikel
80 PO-130: Longitudinal assessment of enteral nutrition requirement in 1st line treatment of SCCHN Falewee (France), M.N.
 2017
 122 S1 p. 62-63
2 p.
 artikel
81 PO-140: Long-term outcomes of surgery ± radiotherapy for salivary gland carcinoma at a single institution Williams, J.
 2017
 122 S1 p. 67-
1 p.
 artikel
82 PO-129: managing the consequences of head and neck in radiotherapy a Radiotherapy Late Effects clinic Christian, J.
 2017
 122 S1 p. 62-
1 p.
 artikel
83 PO-089: Melatonin enhances the toxicity of radio- and chemotherapy in head and neck cancer cells Escames, G.
 2017
 122 S1 p. 43-
1 p.
 artikel
84 PO-127: Melatonin oral gel for prevention oral mucositis head and neck cancer undergoing chemo/bio radiation (MUCOMEL) Lozano, A.
 2017
 122 S1 p. 61-
1 p.
 artikel
85 PO-067: Mucosal Melanoma of the head and neck: single institution experience Viveiros, C.
 2017
 122 S1 p. 33-34
2 p.
 artikel
86 PO-137: Multivariate oral rinse models predict Head and Neck squamous cell carcinoma (HNSCC) Donovan, M.
 2017
 122 S1 p. 66-
1 p.
 artikel
87 PO-058: Nasopharingeal carcinoma treated with intensity modulated radiotherapy in an non–endemic area. Lozano, A.
 2017
 122 S1 p. 29-30
2 p.
 artikel
88 PO-052: N2 node metastasis in squamous cancers of head and neck: failure patterns and future management Giri, S.
 2017
 122 S1 p. 27-
1 p.
 artikel
89 PO-064: Normal tissue complication probability model for tube feeding dependence 6 months after radiotherapy Kanayama, N.
 2017
 122 S1 p. 32-
1 p.
 artikel
90 PO-133: Occult lymphnode metastasis in early stage OPC treated with TORS without neck lymphnodes dissection Alterio, D.
 2017
 122 S1 p. 64-
1 p.
 artikel
91 PO-090: Oncostatic effect of melatonin in head and neck cancer: role of mitochondrial function Escames, G.
 2017
 122 S1 p. 43-44
2 p.
 artikel
92 PO-100: Oral cancer microenvironment - PI3K/AKT/mTOR and ERK/MAPK pathways dependent targets Domingues, C.
 2017
 122 S1 p. 48-
1 p.
 artikel
93 PO-103: Oropharyngeal cancer patient-derived xenografts: Characterization and radiosensitivity. Lilja-Fischer, J.
 2017
 122 S1 p. 49-50
2 p.
 artikel
94 PO-101: Osteopontin (OPN) as an instant, predictive marker of tumour hypoxia in head and neck cancer patients Mrochem-Kwarciak, J.
 2017
 122 S1 p. 48-49
2 p.
 artikel
95 PO-116: Potential applications of spectral CT imaging in patients with head and neck squamous cell carcinoma Peltenburg, B.
 2017
 122 S1 p. 55-56
2 p.
 artikel
96 PO-076: Predictive and prognostic value of pretreatment fdg-pet suv parameters in head-and-neck Deantonio, L.
 2017
 122 S1 p. 36-37
2 p.
 artikel
97 PO-106: Prognostic significance of cyclin D1 and pRb expression in oropharyngeal carcinoma Broglie, M.A.
 2017
 122 S1 p. 51-
1 p.
 artikel
98 PO-122: Psychological profile of patients with head and neck cancer during radiotherapy: preliminary data Massaccesi, M.
 2017
 122 S1 p. 58-
1 p.
 artikel
99 PO-069: Radiation Dose and Distribution Following Transoral Robotic Surgery of the Palatine Tonsil Naqvi, S.
 2017
 122 S1 p. 34-
1 p.
 artikel
100 PO-057: Radiation induced skin reaction in head neck malignancies and assessment of quality of life Pareek, V.
 2017
 122 S1 p. 29-
1 p.
 artikel
101 PO-094: Radiation induced volume changes in Salivary glands in head and neck cancer patients receiving IMRT Borade, D.
 2017
 122 S1 p. 45-
1 p.
 artikel
102 PO-146: Radiotherapy in elderly patients aged ≥ 70 years with head and neck squamous cell carcinoma Metcalfe, E.
 2017
 122 S1 p. 70-
1 p.
 artikel
103 PO-081: Recurrence analysis in head and neck squamous cell carcinoma treated with adjuvant EUD-based IMRT Welz, S.
 2017
 122 S1 p. 39-
1 p.
 artikel
104 PO-131: Resecting the carotid artery for invasive head and neck cancer: Time to reconsider its feasibility Jones, A.
 2017
 122 S1 p. 63-
1 p.
 artikel
105 PO-062: Retrospective analysis of 72 patients treated with FEP regimen and CCRT for locally advanced NPC. Ouhajjou, A.
 2017
 122 S1 p. 31-
1 p.
 artikel
106 PO-134: Retrospective analysis of treatment outcomes of sinonasal malignancies. Our 22-year experience Tarchini, P.
 2017
 122 S1 p. 64-65
2 p.
 artikel
107 PO-132: Risk of re-operation for bleeding in head and neck surgery. Haapio, E.
 2017
 122 S1 p. 63-64
2 p.
 artikel
108 PO-112: Role for interim PET in patient selection for dose escalation and boost volume definition in HNSCC? Lynch, J.
 2017
 122 S1 p. 54-
1 p.
 artikel
109 PO-085: Role of L Glutamine in reducing severity of chemoradiation induced mucositis and improve QoL in HNC Pareek, V.
 2017
 122 S1 p. 40-41
2 p.
 artikel
110 PO-143: Salivary gland tumours: preliminary results of the Trento Protontherapy Centre Giacomelli, I.
 2017
 122 S1 p. 68-69
2 p.
 artikel
111 PO-098: Searching for therapeutic targets from whole transcriptome of oral cancer Roy, B.
 2017
 122 S1 p. 47-
1 p.
 artikel
112 PO-061: Stomal underdose in post-laryngectomy radiotherapy via VMAT: phantom study and clinical case analysis Lee, S.
 2017
 122 S1 p. 30-31
2 p.
 artikel
113 PO-055: Subglottic squamous cell carcinoma in Denmark from 1971-2016 –a report from the DAHANCA-group Hill-Madsen, L.
 2017
 122 S1 p. 28-
1 p.
 artikel
114 PO-149: Survival outcomes for very elderly patients after definitive radiotherapy for head and neck cancer Dixon, L.M.
 2017
 122 S1 p. 71-72
2 p.
 artikel
115 PO-065: Survival outcomes in Unknown Primary with nodal metastases and role of Radiation therapy Srivastava, A.
 2017
 122 S1 p. 32-33
2 p.
 artikel
116 PO-117: Swallowing exercises: Will it really help head and neck cancer patients? Hashem, W.
 2017
 122 S1 p. 56-
1 p.
 artikel
117 PO-109: The added value of SPECT-CT for identification of sentinel lymph nodes in early stage oral cancer Den Toom, I.
 2017
 122 S1 p. 52-53
2 p.
 artikel
118 PO-147: The ELAN program: Customised treatment of SCCHN elderly patients according to geriatric assessment Guigay (France), J.
 2017
 122 S1 p. 70-71
2 p.
 artikel
119 PO-078: The evaluation of the set-up differences between radiation therapists for head and neck patients Kara (Turkey), E.
 2017
 122 S1 p. 37-38
2 p.
 artikel
120 PO-050: The interplay between all-trans-retinoic acid and radiotherapy in inducing cancer stem cell arrest Marcu, L.G.
 2017
 122 S1 p. 26-
1 p.
 artikel
121 PO-088: The study of constant dose rate and gantry speed arc therapy for glottic carcinoma on Varian 23EX Zhang, R.
 2017
 122 S1 p. 42-43
2 p.
 artikel
122 PO-108: TLR induced PDL-1 expression in HNSCC as a potential tool of immunomodulation Wollenberg, B.
 2017
 122 S1 p. 52-
1 p.
 artikel
123 PO-056: Tolerance and outcomes of radical hypofractionated radiotherapy for glottic cancer in the elderly Zeniou, A.
 2017
 122 S1 p. 28-29
2 p.
 artikel
124 PO-075: Treatment of nasopharyngeal cancer: a Serbian institututinal experience Ursulovic, T.
 2017
 122 S1 p. 36-
1 p.
 artikel
125 PO-073: Viable tumour in salvage neck dissections: relation with initial treatment, lymph node size and HPV Van den Bovenkamp, K.
 2017
 122 S1 p. 36-
1 p.
 artikel
126 PO-063: Waiting time and fast track model for head and neck cancer patients in Finland Irjala, H.
 2017
 122 S1 p. 31-32
2 p.
 artikel
127 SP-039: Adenoid cystic carcinoma: considerations in surgical approach and factors modifying expected outcome following treatment Vander Poorten, V.
 2017
 122 S1 p. 21-22
2 p.
 artikel
128 SP-038: Clinical implementation of adaptive radiotherapy: challenges ahead Hamming-Vrieze, O.
 2017
 122 S1 p. 21-
1 p.
 artikel
129 SP-049: Early stage HPV related oropharyngeal cancer should not be treated with radiotherapy anymore against the motion Giralt, J.
 2017
 122 S1 p. 25-26
2 p.
 artikel
130 SP-047: Early stage HPV related oropharyngeal cancer should not be treated with radiotherapy anymore against the motion Budach, V.
 2017
 122 S1 p. 25-
1 p.
 artikel
131 SP-048: Early stage HPV related oropharyngeal cancer should not be treated with radiotherapy anymore: for the motion Klozar, J.
 2017
 122 S1 p. 25-
1 p.
 artikel
132 SP-046: Early stage HPV related oropharyngeal cancer should not be treated with radiotherapy anymore: for the motion Simon, C.
 2017
 122 S1 p. 25-
1 p.
 artikel
133 SP-018: HNC Biomarkers - how do we translate biology into useful assays for clinical care? Seiwert, T.
 2017
 122 S1 p. 12-
1 p.
 artikel
134 SP-036: Immunity and immune toxicity: clinical management of immune checkpoint inhibition Keilholz, U.
 2017
 122 S1 p. 21-
1 p.
 artikel
135 SP-037: Immunotherapy beyond anti PD1 inhibitors Coulie, P.
 2017
 122 S1 p. 21-
1 p.
 artikel
136 SP-001: Immunotherapy for head and neck cancer: integrating the fourth modality Ferris, R.
 2017
 122 S1 p. 6-
1 p.
 artikel
137 SP-024: Integrated 3D virtual visualization of pathology and reconstructive planning in head & neck cancer Witjes, M.
 2017
 122 S1 p. 15-16
2 p.
 artikel
138 SP-035: Is there still a role for targeted signaling agents in head and neck cancer? Le Tourneau, C.
 2017
 122 S1 p. 20-21
2 p.
 artikel
139 SP-023: New developments in sentinel node biopsy of head and neck cancer Stoeckli, S.
 2017
 122 S1 p. 15-
1 p.
 artikel
140 SP-017: New imaging techniques Maroldi, R.
 2017
 122 S1 p. 12-
1 p.
 artikel
141 SP-004: Novel insights into head and neck cancer by transcriptome approaches De Cecco, L.
 2017
 122 S1 p. 6-
1 p.
 artikel
142 SP-025: Oropharyngeal surgery Jones, T.
 2017
 122 S1 p. 16-
1 p.
 artikel
143 SP-015: Prophylactic swallowing exercises in head and neck radiotherapy Mortensen, H.R.
 2017
 122 S1 p. 11-
1 p.
 artikel
144 SP-003: Radiomics: the poor man molecular imaging? Lambin, P.
 2017
 122 S1 p. 6-
1 p.
 artikel
145 SP-040: Radiotherapy in adenoid cystic carcinoma (ACC) of the head and neck Jensen, A.
 2017
 122 S1 p. 22-23
2 p.
 artikel
146 SP-002: State of the art in robotic surgery Moore, E.
 2017
 122 S1 p. 6-
1 p.
 artikel
147 SP-014: Target volume reduction De Neve, W.
 2017
 122 S1 p. 11-
1 p.
 artikel
148 SP-005: The TRIPOD guideline Moons, K.G.M.
 2017
 122 S1 p. 6-
1 p.
 artikel
149 SP-016: the value of proton therapy for head and neck malignancies: reducing side effects and improving outcomes Blanchard, P.
 2017
 122 S1 p. 12-
1 p.
 artikel
150 SP-012: Update of neck dissection trial D'Cruz, A.
 2017
 122 S1 p. 10-
1 p.
 artikel
151 SP-010: Update of the meta-analysis of chemotherapy in head and neck cancer (MACH-NC) Blanchard, P.
 2017
 122 S1 p. 9-
1 p.
 artikel
152 SP-011: Update of the PET NECK trial Mehanna, H.
 2017
 122 S1 p. 9-10
2 p.
 artikel
153 SP-013: Update on the ARCON study Kaanders, J.
 2017
 122 S1 p. 10-11
2 p.
 artikel
154 Title Page 2017
 122 S1 p. i-
1 p.
 artikel
                             154 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland